Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-956-3 | CAS number: 89-98-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
In an experimental study of Rietveld et al. (1988) radiolabelled 14C-2-chlorobenzaldehyde was applied intravenously (25 µl/kg) or intraperitoneally (37.5 µl/kg) to male Wistar rats. Radioactivity was measured in blood, urine, faeces and exhaled air. The test item was rapidly and completely eliminated within 24 hours after intravenous and intraperitoneal application to rats. Excretion was mainly via urine (about 98%) and only small amounts were found in the faeces and exhaled air. Plasma elimination followed a bi-exponential fashion, the 14C half-life during the first elimination phase was 15.6 min.
Furthermore, mercapturic acids were isolated from the urines after continuous dosing with o-chlorobenzaldehyde. The structures of the methyl esters of the isolated substances were confirmed by NMR and mass spectra and were identified as the arylmethyl thioethers of N-acetylcysteine.
A second publication (Rietveld et al. 1986) revealed a benzylmercapturic acid excretion in the urine of 7.6 % of the dose after i.p. administration of 2-chlorobenzaldehyde to rats.
Additionally, Rietveld et al. (1988) showed that cutaneously administered 14C-2-chlorobenzaldehyde (75 µI/kg) was well absorbed by the skin of rats. The major portion of radioactivity was excreted in the urine. Urinary excretion of the radioactivity was found about 45% within the first 24 h post dosing: About 15% of the 75 µl/kg dose of 14C-2-chlorobenzaldehyde was found in the glasscup (semiocclusive cover) and on the skin. The principal metabolite in rat urine was 2-chlorohippuric acid. No part of the urinary radioactivity was present as parent compound and there was no evidence of storage in the skin or skin toxicity of 2-chlorobenzaldehyde following cutaneous application.
Altogether these publications show that 2-chlorobenzaldehyde is extensively biotransformed in mammalians after different routes of application and is mainly excreted in the urine as secondary metabolites in the first 24 hours after dosing.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.